MED.00091 Rhinophototherapy

This policy addresses rhinophototherapy, an intranasal UVA/UVB/visible light treatment proposed for allergic rhinitis and other nasal or sinus conditions. Anthem considers rhinophototherapy investigational and not medically necessary; it is not covered for any indication. Non-coverage applies to all conditions (including allergic rhinitis), the primary device (Rhinolight) lacks FDA clearance, and services may be reported with CPT/HCPCS 30999 but are not reimbursed.

"The use of rhinophototherapy is consideredinvestigational and not medically necessaryfor all conditions, including but not limited to the treatment of allergic rhinitis and other nasal or sinus con..."

Sign up to see full coverage criteria, indications, and limitations.